A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.4, 2005-04, pp. : 569-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

By Hughes R.A.C.

Drugs, Vol. 63, Iss. 3, 2003-01 ,pp. : 275-287

Adis International

Access to resources Recommend Favorite

Newer Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

By Kuitwaard Krista van Doorn Pieter A.

Drugs, Vol. 69, Iss. 8, 2009-06 ,pp. : 987-1001

Adis International

Access to resources Recommend Favorite

Oxaliplatin: Acute inflammatory demyelinating polyradiculoneuropathy: case report

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 35-35

Adis International

Access to resources Recommend Favorite

Chronic Inflammatory Demyelinating Polyneuropathy Possibly Associated with Tacrolimus

By Haviv Y.S. Friedlaender M. Dranitzki-Elhallel M.

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 169-172

Adis International

Access to resources Recommend Favorite

Peginterferon alfa 2b: Chronic inflammatory demyelinating polyneuropathy: case report

Reactions Weekly, Vol. 1, Iss. 1304, 2010-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite